LCC Projects IPO GMP

Listed

LCC Projects IPO GMP & Listing Price

Mainboard · ₹146 · 102 shares/lot · NSE

Final GMP before listing
₹78+53.4%
▼ ₹8 since last reading
17 Sept, 3:34 pm
IST

Range so far: ₹17 low · ₹78 high

9 Sept17 Sept
Listed at
₹189
Listing gain / lot
+₹4,386
Cost / lot
₹14,892

GMP vs actual listing

GMP implied
+53.4%
Listed at
₹189
Actual
+29.5%

Closed its first day at ₹170.1 (+16.5% on the issue price)

LCC Projects carried a grey market premium of ₹78 on an issue price of ₹146, implying a listing around ₹224 (+53.4%). It opened at ₹189, +29.5% — 24.0 points below what the grey market implied.

The premium shown is the one published here before listing, frozen at the bell and never revised afterwards. See all 208 calls, including the misses.

Timeline

  1. Opens
    9 Sept
  2. Closes
    11 Sept
  3. Allotment
    15 Sept
  4. Listing
    17 Sept

Subscription status

as of 17 Sept, 3:34 pm
Total49.57x
Issue typeMainboard
Incorporated2017
SectorCivil Construction
Price₹146
Lot size102 shares
Min investment₹14,892
Issue size₹427.14 Cr
P/E ratio13.87
Face value₹5
RegistrarKFin Technologies
ISININE1FPN01026
Listing atNSE
Listing dateThu, 17 Sept, 2026
NSE symbolLCCPROJECT
BSE code544918

Official documents

LCC Projects IPO FAQs

What was the listing price of LCC Projects IPO?

LCC Projects IPO listed at ₹189 on Thu, 17 Sept, 2026, +29.5% against the issue price of ₹146, a gain of ₹4,386 on one lot of 102 shares. The last grey market premium before listing was ₹78, which implied ₹224.

What was the GMP of LCC Projects IPO before listing?

The last grey market premium for LCC Projects IPO was ₹78, recorded at 3:34 pm IST on Thu, 17 Sept, 2026. That implied +53.4% over the ₹146 price. The stock actually listed +29.5%, so GMP was off by 24.0%.

When was LCC Projects IPO allotment and listing?

Allotment for LCC Projects IPO was finalised on Tue, 15 Sept, 2026 and the shares listed on Thu, 17 Sept, 2026 on NSE. The registrar is KFin Technologies.

GMP is unofficial. Grey market premium is an unregulated, over-the-counter indication with no backing from SEBI, BSE or NSE. It is not a listing-price guarantee and not investment advice. Read the RHP and consult a SEBI-registered adviser before applying.